Literature DB >> 21840742

Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK.

I Das1, P Nightingale, M Patel, P Jumaa.   

Abstract

OBJECTIVES: To review the epidemiology of candidemia in a UK tertiary referral center.
METHODS: Clinical and laboratory data from patients with candidemia were collected prospectively from October 1, 2005 to June 30, 2008 (a 33-month period).
RESULTS: A total of 107 episodes were identified. The incidence was 10.9 episodes/100 000 bed-days. The most common predisposing factors were the use of broad-spectrum antibiotics (92%), the presence of an intravascular device (IVD) (82%), admission to an intensive care unit (ICU) (51%), and recent surgery (50%). Non-Candida albicans species accounted for 58% of the episodes, which is higher than the percentage reported from other UK centers. C. albicans was the most common species, accounting for 43% of episodes, followed by C. glabrata (31%) and C. parapsilosis (20%). Overall C. tropicalis, C. krusei, C. norvegensis, and C. lusitaniae caused 7% of episodes. The crude 30-day mortality rate was 37%. Advanced age (p = 0.003) and the presence of septic shock (p = 0.038) were associated with mortality.
CONCLUSIONS: Candidemia continues to be associated with a high mortality. Preventative measures should be targeted against high-risk hospitalized patients, especially those in ICUs, the elderly, and those undergoing major surgery. Local surveillance of candidemia is important to optimize management.
Copyright © 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840742     DOI: 10.1016/j.ijid.2011.06.006

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  43 in total

1.  The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients.

Authors:  Inge C Gyssens; Winfried V Kern; David M Livermore
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

2.  Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.

Authors:  Hugo Dias Hoffmann-Santos; Claudete Rodrigues Paula; Ana Caroline Akeme Yamamoto; Tomoko Tadano; Rosane C Hahn
Journal:  Mycopathologia       Date:  2013-10-11       Impact factor: 2.574

3.  Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.

Authors:  S J Taj-Aldeen; A Kolecka; R Boesten; A Alolaqi; M Almaslamani; P Chandra; J F Meis; T Boekhout
Journal:  Infection       Date:  2013-12-19       Impact factor: 3.553

4.  Evaluation of Candida bloodstream infection and antifungal utilization in a tertiary care hospital.

Authors:  Tatiana Aporta Marins; Alexandre R Marra; Michael B Edmond; Marines Dalla Valle Martino; Paula Kiyomi Onaga Yokota; Ana Carolina Cintra Nunes Mafra; Marcelino Souza Durão Junior
Journal:  BMC Infect Dis       Date:  2018-04-18       Impact factor: 3.090

5.  Candida krusei and Candida glabrata reduce the filamentation of Candida albicans by downregulating expression of HWP1 gene.

Authors:  Patrícia Pimentel de Barros; Fernanda Freire; Rodnei Dennis Rossoni; Juliana Campos Junqueira; Antonio Olavo Cardoso Jorge
Journal:  Folia Microbiol (Praha)       Date:  2017-02-06       Impact factor: 2.099

6.  Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species.

Authors:  Plinio Trabasso; Tetsuhiro Matsuzawa; Renata Fagnani; Yasunori Muraosa; Kenichiro Tominaga; Mariangela Ribeiro Resende; Katsuhiko Kamei; Yuzuru Mikami; Angelica Zaninelli Schreiber; Maria Luiza Moretti
Journal:  Mycopathologia       Date:  2014-12-07       Impact factor: 2.574

7.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

8.  Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil.

Authors:  Marcos Paulo Wille; Thaís Guimarães; Guilherme Henrique Campos Furtado; Arnaldo Lopes Colombo
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

9.  Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014.

Authors:  Laura Milazzo; Anna Maria Peri; Cristina Mazzali; Romualdo Grande; Chiara Cazzani; Davide Ricaboni; Antonio Castelli; Ferdinando Raimondi; Carlo Magni; Massimo Galli; Spinello Antinori
Journal:  Mycopathologia       Date:  2014-07-24       Impact factor: 2.574

10.  Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey.

Authors:  I Faria-Ramos; J Neves-Maia; E Ricardo; J Santos-Antunes; A T Silva; S Costa-de-Oliveira; E Cantón; A G Rodrigues; C Pina-Vaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.